Attached files
| file | filename |
|---|---|
| EX-10.4 - EXHIBIT 10.4 - Brooklyn ImmunoTherapeutics, Inc. | brhc10022537_ex10-4.htm |
| EX-10.3 - EXHIBIT 10.3 - Brooklyn ImmunoTherapeutics, Inc. | brhc10022537_ex10-3.htm |
| EX-10.2 - EXHIBIT 10.2 - Brooklyn ImmunoTherapeutics, Inc. | brhc10022537_ex10-2.htm |
| EX-10.1 - EXHIBIT 10.1 - Brooklyn ImmunoTherapeutics, Inc. | brhc10022537_ex10-1.htm |
| EX-3.4 - EXHIBIT 3.4 - Brooklyn ImmunoTherapeutics, Inc. | brhc10022537_ex3-4.htm |
| EX-3.2 - EXHIBIT 3.2 - Brooklyn ImmunoTherapeutics, Inc. | brhc10022537_ex3-2.htm |
| EX-3.1 - EXHIBIT 3.1 - Brooklyn ImmunoTherapeutics, Inc. | brhc10022537_ex3-1.htm |
| 8-K - 8-K - Brooklyn ImmunoTherapeutics, Inc. | brhc10022537_8k.htm |
Exhibit 3.3
CERTIFICATE OF AMENDMENT
OF
RESTATED CERTIFICATE OF INCORPORATION
OF
NTN BUZZTIME, INC.
NTN Buzztime, Inc. (the “Corporation”), a
corporation organized and existing under the General Corporation Law of the State of Delaware, does hereby certify that:
| 1. |
This Certificate of Amendment (the “Certificate of Amendment”) hereby
amends the Corporation’s Restated Certificate of Incorporation (as amended prior to the date hereof, the “Certificate of Incorporation”)
as set forth herein.
|
| 2. |
Article I of the Certificate of Incorporation is hereby amended and restated in its entirety as follows:
|
“The name of the corporation (the “Corporation”) is Brooklyn ImmunoTherapeutics, Inc.”
| 3. |
The foregoing amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.
|
| 4. |
All other provisions of the Certificate of Incorporation shall remain in full force and effect.
|
IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by its duly authorized officer this
25th day of March 2021.
|
NTN Buzztime, Inc.
|
|||
|
By:
|
/s/ Allen Wolff
|
||
|
Name: Allen Wolff
|
|||
|
Title: Chief Executive Officer
|
|||